Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 14 July

Paulina Peters
July 14, 2022

Morning Bell 13 July

Sophia Mavridis
July 13, 2022

Morning Bell 12 July

Paulina Peters
July 12, 2022

Morning Bell 11 July

Sophia Mavridis
July 11, 2022

Weekly Wrap 8 July

Sophia Mavridis
July 8, 2022

Morning Bell 7 July

Paulina Peters
July 7, 2022

Morning Bell 6 July

Sophia Mavridis
July 6, 2022

Morning Bell 5 July

Paulina Peters
July 5, 2022

Morning Bell 4 July

Sophia Mavridis
July 4, 2022

Weekly Wrap 1 July

Sophia Mavridis
July 1, 2022

Morning Bell 30 June

Paulina Peters
June 30, 2022